Abstract
30Apr 2016 CAN RESECTION OF LIVER METASTASIS IMPROVE SURVIVAL AFTER RESECTABILITY CONVERSION CHEMOTHERAPY IN PATIENTS WITH METASTATIC COLO-RECTAL CANCER? Ahmed A Alnagar , Wael mansy , Morsi Mohamed , Alaa A Farag and Lobna A. Abdelaziz. Medical Oncology Department, Faculty of Medicine, Zagazig University, Sharkia, Egypt. General Surgery department, Faculty of Medicine, Zagazig University, Sharkia, Egypt. Internal Medicine Department, Faculty of Medicine, Zagazig University, Sharkia, Egypt. Clinical Oncology Department, Faculty of Medicine, Zagazig University, Sharkia, Egypt.
Highlights
Colon-rectal cancer is the fourth most frequent cancer worldwide, 35%-50% develop metastasis, 60%- 80% of them have unresectable liver metastasis, 20% to 34% present with synchronous liver metastasis, while the others are metachronous, only 15%-20% will be candidate for hepatectomy, While chemotherapy can convert around 10% to resectability, R0 surgical resection leads to improvement in median 5-years survival in patients with resected liver metastasis
The median OS was not reached in the resected group The estimated mean OS for the unresectable group was 15.7±0.96(95% CI 13.8-17.6) compared to 20.1±1.24(95% CI 17.7-22.6) in the resected group that is statistically significant different withp-value 0.015
Conclusion:chemotherapy can help in resectability conversion of unresectable liver metastasis
Summary
CAN RESECTION OF LIVER METASTASIS IMPROVE SURVIVAL AFTER RESECTABILITY CONVERSION CHEMOTHERAPY IN PATIENTS WITH METASTATIC COLO-RECTAL CANCER?. Ahmed A Alnagar1,Wael mansy[2], Morsi Mohamed[2], Alaa A Farag[3], Lobna A. 1. Medical Oncology Department, Faculty of Medicine, Zagazig University, Sharkia, Egypt. 2. General Surgery department, Faculty of Medicine, Zagazig University, Sharkia, Egypt. 3. Internal Medicine Department, Faculty of Medicine, Zagazig University, Sharkia, Egypt. 4. Clinical Oncology Department, Faculty of Medicine, Zagazig University, Sharkia, Egypt
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.